For Professional Clients and, in Switzerland, for Qualified Investors only. In Israel for Sophisticated Investors only.
English
  • English
  • French
en
  • en
  • fr
Filter by theme
Filter by date
Filter by boutique
Filter by theme
Filter by date
Filter by boutique
No posts matching your criteria
Clear theme
Clear all
No posts matching your criteria
Clear date
Clear all
No posts matching your criteria
Clear boutique
Clear all
For Professional Clients and, in Switzerland, for Qualified Investors only. In Israel for Sophisticated Investors only.
English
  • English
  • French
en
  • en
  • fr
© 2019. BNY Mellon Investment Management International Limited. All rights reserved.
IDEAS AND KNOWLEDGE TO INSPIRE YOUR INVESTMENTS THINKING
28 March 2019

Is social media the right prescription for health?

Trends such as increasing out-of-pocket spend are changing the way investors need to think about those who access healthcare. The difference between being a patient or a consumer is an important one. To ensure the highest levels of safety, regulation in the healthcare market largely prescribes how the patient should receive care from those who provide it. Visibility on cost, value and access is often limited. Ideas such as choice, flexibility, and brand loyalty are concepts that are relatively alien to us as patients.

 

In contrast examples from the retail sector already show us how the decisions made by consumers are increasingly being shaped through social media and influencer marketing. As we are all asked to become more responsible for our own general health, wellness, fitness and nutrition these same channels will, over time, also begin to drive decisions by those who use health care. As patients make more of their own choices as individuals or as groups with common health needs, we will find the difference between the patient and consumer may turn out to be not that different after all.

 

Stephen Rowntree – global healthcare analyst. Newton, a BNY Mellon company

Please note the content on this website is for Investment Professionals only and should be shared responsibly. No other persons should rely on the information contained within this website.

Investment Managers are appointed by BNY Mellon Investment Management EMEA Limited (BNYMIM EMEA) or affiliated fund operating companies to undertake portfolio management activities in relation to contracts for products and services entered into by clients with BNYMIM EMEA or the BNY Mellon funds.

Subscribe to updates